Psoriasis Treatment Market Report for Period 2017 till 2022 Pfizer, Merck and Co, AbbVie, Amgen with CAGR of 7.3%

Synopsis of Global Psoriasis Treatment Market

Market Scenario

Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals directing skin cells to grow too quickly. New skin cells forms in days rather than weeks resulting in their pilling up on the surface of the skin, causing patches of psoriasis. Most of the time it also affects fingers and nails resulting in painful disfiguration and partial disability. Psoriasis affects mostly knees, elbows, and scalp, but other body parts may also be affected. Thus, it has a heavy negative effect on the quality of life and results in social stigma.

Although it can occur at any age but most commonly it occurs in the age group of 50–70. The exact cause and etiology of psoriasis is still unknown but usually auto-immunity, genetics and environmental factors are involved. Psoriasis is also associated with a host of co-morbidities such as psoriatic arthritis, ophthalmologic pathologies, diabetes, inflammatory bowel disease etc. According to the World Health Organization (WHO), 1.3% to 34.7% of individuals with psoriasis develop chronic psoriatic arthritis which may lead to joint deformations and disability. From 4.2% to 69% of all patients suffering from psoriasis develop nail changes. WHO also predicts that psoriasis affects about 100 million people with prevalence rates ranging from 0.09% to 11.43% in different countries. Plaque psoriasis is the most common form of psoriasis affecting 90% of all cases of psoriasis.

Psoriasis Treatment Market was valued to be US$7.0 billion in 2016 and is expected to reach US$10.68 billion by 2022. Thus the market is expected to grow at a CAGR of 7.3% from 2016 to 2022.

Rise in screening and growing prevalence of psoriasis remains the most critical market driving factor of the global psoriasis treatment market. In general an upward trend is observed in several countries throughout the world. For example data from the national health and nutrition examination survey revealed that in United States prevalence of psoriasis increased from 1.62% to 3.10% from 2004 to 2010.

The other market driving factors for the global psoriasis treatment market is growing awareness, rise in risk factors such as autoimmune diseases, diabetes etc. and greater exposure to environmental factors such as chemicals, allergens etc.

Key Players for Global Psoriasis Treatment Market

• Some of the key players of this market are namely
• Novartis International AG
• Johnson & Johnson
• Pfizer Inc
• Merck and Co
• AbbVie
• Amgen
• Eli Lilly.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2769.

Market Segments:

Global psoriasis treatment market has been segmented on the basis of mechanism of action, route of administration and by drug types.
Regional Analysis of Global Psoriasis Treatment Market
Globally North America is the largest market of global psoriasis treatment. Europe is the second largest market for global psoriasis treatment. However the developing market is Asia Pacific that will be the fastest growing region and will be the key to the future.

Study Objectives Global Psoriasis Treatment market:

• To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the global psoriasis treatment market.
• To provide insights about factors affecting the market growth.
• To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
• To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries including Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future growth prospect.
• To provide country level analysis of the market for segments by mechanism of action (TNF inhibitors, phsophodiesterase inhibitors, interleukin blockers and others), by route of administration (oral, tropical and injectable) and by drug types (small molecules and biologics)
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments globally.

Browse Report @ https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769 .

Table Of Contents:
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Psoriasis Treatment Market, By Mechanism Of Action
6 Global Psoriasis Treatment Market, By Route Of Administration
7 Global Psoriasis Treatment Market, By Drug Types
8 Global Psoriasis Treatment Market, By Regions
9 Company Landscape
10 Company Profile
11 Others
12 Appendix

List Of Tables

TABLE 1 GLOBAL PSORIASIS TREATMENT MARKET, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL PSORIASIS TREATMENT MARKET, BY MECHANISM OF ACTION, 2013-2022 (USD MILLION)
TABLE 3 GLOBAL PSORIASIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2013-2022 (USD MILLION)
TABLE 4 GLOBAL PSORIASIS TREATMENT MARKET, BY DRUG TYPES, 2013-2022 (USD MILLION)
TABLE 5 GLOBAL PSORIASIS TREATMENT MARKET, BY REGION, 2013-2022 (USD MILLION)

List Of Figures

FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL PSORIASIS TREATMENT MARKET, BY MECHANISM OF ACTION
FIGURE 4 GLOBAL PSORIASIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
FIGURE 5 GLOBAL PSORIASIS TREATMENT MARKET, BY DRUG TYPES
FIGURE 6 GLOBAL PSORIASIS TREATMENT MARKET, BY REGION
FIGURE 7 GLOBAL PSORIASIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

Check Discount for this Report @ https://www.marketresearchfuture.com/check-discount/2769.

Intended Audience

• Global psoriasis drugs manufacturers
• Research and development laboratories
• Market research and consulting service providers

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.